Daniel Friedman

Managing Director at BroadOak Capital

Speaker

Daniel Friedman is a Managing Director on BroadOak’s investing team, covering the firm's life science tools portfolio, with a focus on products with cell and gene therapy applications. Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for biotechnology and medical device companies.Daniel currently serves as a director on the boards of PBS Biotech and Precision Cell Systems, as well as acting as an observer at Axol, Pluristyx, and Biolog.